Clinical Cancer Research  Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chinni, S. R.
Right arrow Articles by Sarkar, F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chinni, S. R.
Right arrow Articles by Sarkar, F. H.
Clinical Cancer Research Vol. 8, 1228-1236, April 2002
© 2002 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Akt Inactivation Is a Key Event in Indole-3-carbinol-induced Apoptosis in PC-3 Cells1

Sreenivasa R. Chinni and Fazlul H. Sarkar2

Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201

Indole-3-carbinol (I3C) is a bioactive compound present in Brassica vegetables that shows an antitumor activity in experimental animals and inhibits the growth of human cancer cells in vitro. In recent years, studies on prostate cancer (PCa) chemoprevention have been intensified, because there is a long latency for the development of clinical PCa, which makes the PCa a better target for chemoprevention. We have shown previously that I3C induces cell growth inhibition by G1 cell cycle arrest and induces apoptosis in a dose- and time-dependent manner in PC-3 PCa cells; however, the mechanism(s) by which I3C induces apoptosis in PC-3 cells is still not clear. A cell survival pathway involving phosphatidylinositol 3'-kinase (PI3K) and Akt is known to play an important role in inhibiting apoptosis in response to growth factor signaling, which prompted us to investigate whether this pathway plays any role in I3C-induced apoptosis in PCa cells. Here we report that I3C inhibits the phosphorylation and subsequent activation of Akt kinase. In addition, I3C abrogated epidermal growth factor (EGF)-induced activation of Akt in PC-3 cells. Western blot analyses of EGF receptor showed that I3C down-regulates the EGF receptor levels and its autophosphorylation. This was also accompanied by the inhibition of EGF-induced phosphorylation of PI3K by I3C treatment. Furthermore, the known downstream modulators of the Akt/PI3K cell survival pathway, Bcl-xL, and BAD proteins showed decreased expression after I3C treatment. From these results, we conclude that I3C-induced apoptosis is partly mediated by the inhibition of Akt activation, resulting in the alterations in the downstream regulatory molecules of Akt activation in PC-3 cells. However, further in-depth investigation is needed to establish a cause-and-effect relationship between Akt pathway and I3C effect.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
S. Ali, S. Banerjee, A. Ahmad, B. F. El-Rayes, P. A. Philip, and F. H. Sarkar
Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer
Mol. Cancer Ther., June 1, 2008; 7(6): 1708 - 1719.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Z. Wang, B. W. Yu, K. W. Rahman, F. Ahmad, and F. H. Sarkar
Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip
Mol. Cancer Ther., February 1, 2008; 7(2): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F.-M. Lin, L.-R. Chen, E.-H. Lin, F.-C. Ke, H.-Y. Chen, M.-J. Tsai, and P.-W. Hsiao
Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells
Carcinogenesis, December 1, 2007; 28(12): 2521 - 2529.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-R. Weng, C.-H. Tsai, S. K. Kulp, D. Wang, C.-H. Lin, H.-C. Yang, Y. Ma, A. Sargeant, C.-F. Chiu, M.-H. Tsai, et al.
A Potent Indole-3-Carbinol Derived Antitumor Agent with Pleiotropic Effects on Multiple Signaling Pathways in Prostate Cancer Cells
Cancer Res., August 15, 2007; 67(16): 7815 - 7824.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. A. Crowell, V. E. Steele, and J. R. Fay
Targeting the AKT protein kinase for cancer chemoprevention
Mol. Cancer Ther., August 1, 2007; 6(8): 2139 - 2148.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Kopelovich, J. R. Fay, C. C. Sigman, and J. A. Crowell
The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1330 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Kassie, L. B. Anderson, R. Scherber, N. Yu, D. Lahti, P. Upadhyaya, and S. S. Hecht
Indole-3-carbinol Inhibits 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Plus Benzo(a)pyrene-Induced Lung Tumorigenesis in A/J Mice and Modulates Carcinogen-Induced Alterations in Protein Levels
Cancer Res., July 1, 2007; 67(13): 6502 - 6511.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. P. Moiseeva, R. Heukers, and M. M. Manson
EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells
Carcinogenesis, February 1, 2007; 28(2): 435 - 445.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. F. El-Rayes, S. Ali, I. F. Ali, P. A. Philip, J. Abbruzzese, and F. H. Sarkar
Potentiation of the Effect of Erlotinib by Genistein in Pancreatic Cancer: The Role of Akt and Nuclear Factor-{kappa}B
Cancer Res., November 1, 2006; 66(21): 10553 - 10559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Chen, J. Xu, N. Jhala, P. Pawar, Z. B. Zhu, L. Ma, C.-H. Byon, and J. M. McDonald
Fas-Mediated Apoptosis in Cholangiocarcinoma Cells Is Enhanced by 3,3'-Diindolylmethane through Inhibition of AKT Signaling and FLICE-Like Inhibitory Protein
Am. J. Pathol., November 1, 2006; 169(5): 1833 - 1842.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. W. Rahman, F. H. Sarkar, S. Banerjee, Z. Wang, D. J. Liao, X. Hong, and N. H. Sarkar
Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.
Mol. Cancer Ther., November 1, 2006; 5(11): 2747 - 2756.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Xiao and S. V. Singh
Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells
Carcinogenesis, March 1, 2006; 27(3): 533 - 540.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. M. Howells, E. A. Hudson, and M. M. Manson
Inhibition of Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Is Not Sufficient to Account for Indole-3-Carbinol-Induced Apoptosis in Some Breast and Prostate Tumor Cells
Clin. Cancer Res., December 1, 2005; 11(23): 8521 - 8527.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. A. Reed, K. S. Peterson, H. J. Smith, J. C. Gray, D. K. Sullivan, M. S. Mayo, J. A. Crowell, and A. Hurwitz
A Phase I Study of Indole-3-Carbinol in Women: Tolerability and Effects
Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1953 - 1960.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Takada, M. Andreeff, and B. B. Aggarwal
Indole-3-carbinol suppresses NF-{kappa}B and I{kappa}B{alpha} kinase activation, causing inhibition of expression of NF-{kappa}B-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells
Blood, July 15, 2005; 106(2): 641 - 649.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. W. Rahman and F. H. Sarkar
Inhibition of Nuclear Translocation of Nuclear Factor-{kappa}B Contributes to 3,3'-Diindolylmethane-Induced Apoptosis in Breast Cancer Cells
Cancer Res., January 1, 2005; 65(1): 364 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. H. Sarkar and Y. Li
Indole-3-Carbinol and Prostate Cancer
J. Nutr., December 1, 2004; 134(12): 3493S - 3498S.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. J. Anderton, M. M. Manson, R. D. Verschoyle, A. Gescher, J. H. Lamb, P. B. Farmer, W. P. Steward, and M. L. Williams
Pharmacokinetics and Tissue Disposition of Indole-3-carbinol and Its Acid Condensation Products after Oral Administration to Mice
Clin. Cancer Res., August 1, 2004; 10(15): 5233 - 5241.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. E. Blask, R. T. Dauchy, L. A. Sauer, and J. A. Krause
Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin
Carcinogenesis, June 1, 2004; 25(6): 951 - 960.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. H. Fowke, F.-L. Chung, F. Jin, D. Qi, Q. Cai, C. Conaway, J.-R. Cheng, X.-O. Shu, Y.-T. Gao, and W. Zheng
Urinary Isothiocyanate Levels, Brassica, and Human Breast Cancer
Cancer Res., July 15, 2003; 63(14): 3980 - 3986.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. H. Sarkar, K. M. W. Rahman, and Y. Li
Bax Translocation to Mitochondria Is an Important Event in Inducing Apoptotic Cell Death by Indole-3-Carbinol (I3C) Treatment of Breast Cancer Cells
J. Nutr., July 1, 2003; 133(7): 2434S - 2439.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. T. Le, C. M. Schaldach, G. L. Firestone, and L. F. Bjeldanes
Plant-derived 3,3'-Diindolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells
J. Biol. Chem., May 30, 2003; 278(23): 21136 - 21145.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. Li, X. Li, and F. H. Sarkar
Gene Expression Profiles of I3C- and DIM-Treated PC3 Human Prostate Cancer Cells Determined by cDNA Microarray Analysis
J. Nutr., April 1, 2003; 133(4): 1011 - 1019.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.